NeuBase Therapeutics, Inc. announced the appointment of Todd P. Branning as Chief Financial Officer (CFO). Prior to joining NeuBase, Mr. Branning was CFO of Phathom Pharmaceuticals, Inc. Before that, he was Senior Vice President, CFO of Amneal Pharmaceuticals, Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.378 USD | -3.20% | 0.00% | -48.93% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |